Vanguard Group
LEXX icon

Vanguard Group’s Lexaria Bioscience LEXX Stock Holding History

Vanguard Group’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$160K Hold
17,254
– – ﹤0.01% 4132
2025
Q3 		$247K Buy
17,254
+8,350
+94% +$121K ﹤0.01% 4092
2025
Q2 		$116K Buy
8,904
+379
+4% +$6.53K ﹤0.01% 4138
2025
Q1 		$219K Buy
8,525
+29
+0.3% +$738 ﹤0.01% 4056
2024
Q4 		$268K Buy
8,496
+1,228
+17% +$45.3K ﹤0.01% 4058
2024
Q3 		$333K Buy
7,268
+1,029
+16% +$49.1K ﹤0.01% 4057
2024
Q2 		$260K Buy
6,239
+562
+10% +$25.3K ﹤0.01% 4130
2024
Q1 		$309K Buy
5,677
+2,594
+84% +$99.2K ﹤0.01% 4109
2023
Q4 		$57.8K Buy
3,083
+861
+39% +$16.6K ﹤0.01% 4357
2023
Q3 		$33.3K Hold
2,222
– – ﹤0.01% 4454
2023
Q2 		$24.3K Hold
2,222
– – ﹤0.01% 4510
2023
Q1 		$90.7K Hold
2,222
– – ﹤0.01% 4417
2022
Q4 		$82K Buy
2,222
+11
+0.5% +$395 ﹤0.01% 4410
2022
Q3 		$81K Sell
2,211
-64
-3% -$2.73K ﹤0.01% 4509
2022
Q2 		$102K Hold
2,275
– – ﹤0.01% 4548
2022
Q1 		$112K Hold
2,275
– – ﹤0.01% 4588
2021
Q4 		$138K Buy
2,275
+219
+11% +$18.7K ﹤0.01% 4591
2021
Q3 		$193K Buy
2,056
+324
+19% +$31.1K ﹤0.01% 4488
2021
Q2 		$182K Buy
+1,732
New +$155K ﹤0.01% 4376

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group's LEXX Position: Q4 2025 in Review

Vanguard Group held its Lexaria Bioscience (LEXX) position steady in Q4 2025 at 17,254 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #4132.

Vanguard Group first reported a position in LEXX in Q2 2021 and has held it in 19 quarters since. The position peaked at $333K in Q3 2024. 20 funds tracked by Wall St. Rank hold LEXX as of Q4 2025.

  • Vanguard Group held 17,254 shares of Lexaria Bioscience worth $160K as of Q4 2025.
  • Vanguard Group left its Lexaria Bioscience share count unchanged in Q4 2025.
  • Lexaria Bioscience made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4132 holding.
  • Vanguard Group first reported a position in Lexaria Bioscience in Q2 2021 and has held it in 19 quarters since.
  • Vanguard Group's Lexaria Bioscience position peaked at $333K in Q3 2024.
  • 20 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.